Aleafia Health Stock News

TORONTO, June 22, 2022 (GLOBE NEWSWIRE) -- Aleafia Health Inc. (TSX: AH, OTCQX: ALEAF) (“Aleafia Health” or the “Company”) is postponing the announcement of its fifth quarter and fiscal year r

TORONTO, June 15, 2022 (GLOBE NEWSWIRE) -- Aleafia Health Inc. (TSX: AH, OTCQX: ALEAF) (“Aleafia Health” or the “Company”) will announce on June 23 prior to market open its fifth quarter and f

Aleafia Health Inc. (OTC: ALEAF ) reported its financial results this week for the three and 12 months ended Dec 31, revealing quarterly revenue of $8.8 million compared with $15.2 million in the fourth quarter of last year, representing a 9% sequential drop. Recreational sales increased to $6 million. However, medical and bulk sales decreased to $2.5 million and $0.5 million, respectively. The company said that it would ramp up branded sales in both adult-use and medical segments as well as reduce exposure to the bulk market. In the management discussion and analysis section of its annual report, Aleafia set the following guidance range for fiscal 2023: Net sales of $53 million - $63 million. Attaining a top 10 market position in the recreational market … Full story available on Benzinga.com

Aleafia Health Inc. (OTC: ALEAF) reported its financial results this week for the three and 12 months ended Dec 31, revealing quarterly revenue of $8.8 million compared with $15.2 million in the fourt

Aleafia Health, Inc. (ALEAF) CEO Tricia Symmes on Q4 2021 Results - Earnings Call Transcript

Aleafia Health Inc. (TSX:AH) (OTCQX: ALEAF ) reported its financial results for the three and 12 months ended Dec, 31, reporting quarterly revenue of $8.8 million compared with $15.2 million in Q4 2020 . "The core strategic objectives that will drive Aleafia Health to sustained profitability reflect a pivot to focus on branded cannabis revenue. Branded revenue is comprised of ‘sticky,’ recurring medical revenue at attractive gross margins and robust growth in adult-use cannabis revenue where Aleafia continues to aggressively take market share,” Aleafia Health CEO Tricia Symmes stated. “We are focused on achieving Top 10 in total LP market share in 2022, driven by leadership in the value cannabis category. " Financial Highllithts Net revenue was $36.1 million for the 12 months ended December 31, 2021, compared to $44.5 million in the 12 months ending December 31, 2020. The decline in net revenue was based on shifting from lower margin, higher volume bulk wholesale commodity cannabis revenue to higher margin, higher potency and innovative adult-use products, offering a unique value proposition.

Aleafia Health Inc. (TSX:AH) (OTCQX:ALEAF) reported its financial results for the three and 12 months ended Dec, 31, reporting quarterly revenue of $8.8 million compared with $15.2 million in Q4 2020.

Aleafia Health press release (ALEAF): Q4 net loss of $71.51MRevenue of $8.8M (-42.1% Y/Y).

TORONTO, Feb. 14, 2022 (GLOBE NEWSWIRE) -- Aleafia Health Inc. (TSX: AH, OTCQX: ALEAF) (“ Aleafia Health ” or the “ Company ”) is pleased to report its financial results for the three and 12 months ended December 31, 2021. The Company’s 2021 unaudited, consolidated financial statements and management discussion and analysis for the fourth quarter and 12-month periods will be available in the Investors section of the Company’s website at aleafiahealth.com and will be filed on SEDAR and available at sedar.com.

TORONTO, Feb. 08, 2022 (GLOBE NEWSWIRE) -- Aleafia Health Inc. (TSX: AH, OTCQX: ALEAF) (“Aleafia Health” or the “Company”) will announce results from its three and 12-month periods ending December 31, 2021 on February 14, 2022. The Company will also host its earnings conference call on February 15 at 9:30 a.m. EST. The call will be hosted by CEO Tricia Symmes and CFO Matt Sale.

Aleafia Health Inc. AH ALEAF will announce results from its three and 12-month periods ending December 31, 2021 on February 14, 2022. The Toronto-based company will also host its earnings conference c

TORONTO, Feb. 08, 2022 (GLOBE NEWSWIRE) -- Aleafia Health Inc. (TSX: AH, OTCQX: ALEAF) (“Aleafia Health” or the “Company”) will announce results from its three and 12-month periods ending Dece

Aleafia Health Inc. ALEAF is providing a corporate update regarding its outstanding listed unsecured convertible debentures AH, issued on June 27, 2019 and maturing on June 27, 2022. Key Points:

Penny Stocks To Watch For 2022 The post Top Marijuana Penny Stocks To Buy Under $1? 2 To Put On Your Watchlist Next Week appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a

Aleafia Health Inc. (TSX:AH) (OTCQX:ALEAF) announced Wednesday that it is closing its credit facility of up to $19 million. The financing provides the Toronto-based company with liquidity to fund ope